Gout in the first metatarsophalangeal joint: The acute attack and professional aftercare

What lies behind it

The first metatarsophalangeal joint, anatomically referred to as articulatio metatarsophalangealis prima, is the joint most commonly affected by acute gout. The underlying cause of this metabolic disorder is an elevated level of uric acid in the blood plasma, known as hyperuricaemia. If the uric acid concentration exceeds the thermodynamic solubility limit of approximately 6.8 milligrams per decilitre at normal body temperature, uric acid precipitates in the form of sharp-edged monosodium urate crystals.

These microcrystals preferentially deposit in synovial tissues, tendon structures, and cartilage. The first metatarsophalangeal joint is particularly vulnerable to this crystallisation for several biological reasons. Firstly, the periphery of the foot has a lower tissue temperature than joints closer to the body trunk. Reduced temperature significantly lowers the solubility of uric acid. Secondly, during the roll-over phase of walking, the joint is subjected to continuous micromechanical stress, which promotes deposition within the cartilage and capsular layers.

When urate crystals floating in or attached to the joint space are phagocytosed by neutrophilic granulocytes, these inflammatory cells disintegrate and release lysosomal enzymes as well as pro-inflammatory cytokines such as interleukin-1 beta. This biochemical cascade triggers a massive, localized inflammatory response. Within a few hours, the joint swells significantly, the synovial membrane becomes severely inflamed, and the surrounding soft tissue exhibits marked hyperaemia.

Typical signs

In more than eighty percent of first manifestations, the acute attack occurs without warning, very frequently in the early morning hours. Pain reaches its maximum intensity within a few hours. The skin over the first metatarsophalangeal joint becomes taut, assumes a shiny, bright red to livid-violet discolouration, and reacts with extreme sensitivity to touch. Even a light draught of air or a gentle touch on the skin triggers severe pain signals.

In addition to pain, the joint exhibits significant functional impairment. Normal roll-over of the foot during the stance and push-off phases of the gait cycle becomes impossible. Affected individuals automatically shift weight to the outer edge of the foot, which rapidly leads to secondary mechanical overload in the metatarsal area and calf muscles. The sensation of localized heat is palpable and clearly demarcated.

Gout must be differentiated from other conditions presenting with similar symptoms. These include septic arthritis, in which bacteria have invaded the joint space, requiring immediate emergency surgical and antibiotic treatment. Pseudogout, caused by calcium pyrophosphate dihydrate crystals, also presents with related symptoms but more commonly affects the knee or wrist joint. Furthermore, activated osteoarthritis of the first metatarsophalangeal joint (hallux rigidus) and advanced inflammatory stages of hallux valgus must be ruled out.

Everyday causes

Elevated uric acid concentration is primarily genetic when renal excretion of uric acid via the renal tubules is reduced. However, lifestyle factors and everyday influences act as direct triggers for exceeding the solubility threshold. A sudden increase in uric acid often occurs after consuming purine-rich foods such as red meat, offal, seafood, or certain types of fish. In the human organism, purines are broken down into uric acid via the enzyme xanthine oxidase.

Alcohol consumption plays an equally significant role. Ethanol promotes the breakdown of adenosine triphosphate in the liver, increasing uric acid synthesis, while simultaneously inhibiting the renal excretion of uric acid in the renal pelvis in the form of lactate. Fructose-containing beverages and industrially sweetened foods also lead to accelerated purine breakdown via hepatic fructose metabolism.

Beyond diet, physical factors acting on the foot serve as local triggers. Tight, constricting footwear exerts mechanical pressure on the first metatarsophalangeal joint. When the toe box pushes the first ray laterally, peak tension occurs in the joint capsule tissue. When this mechanical irritation is combined with reduced fluid intake or heavy sweating, the local uric acid concentration in the tissue increases drastically. Microtrauma from unaccustomed hiking or athletic exertion can also release crystals from existing deposits, initiating the inflammatory cascade.

When medical evaluation is necessary

A suspected gout attack always requires medical diagnosis by a physician. A definitive diagnosis can only be made through laboratory testing of blood parameters and, if necessary, sonography or joint aspiration. Confusing gout with infectious bacterial arthritis without specialist evaluation can have serious consequences for joint preservation.

Medical consultation is imperative if the following symptoms occur:

• Accompanying fever, chills, or a general feeling of illness, as these signs may indicate a systemic infection.
• Continuous increase in swelling beyond the ankle joint or clear accumulations of pus under the skin.
• Recurrent attacks despite lifestyle modifications, in order to initiate permanent medical lowering of uric acid.
• Palpable, painless, or mildly tender nodules under the skin on the toes, auricles, or elbows, known as gouty tophi.

Permanently untreated hyperuricaemia not only leads to irreversible joint damage with cartilage loss and bone erosion, but also damages renal tissue. The precipitation of urate crystals in the renal interstitium can result in urate nephropathy and kidney stones.

What podiatric treatment can achieve

Once the acute inflammatory phase has subsided and the joint is no longer severely painful, professional care in the podiatry practice begins. The primary objective of podiatric care during the symptom-free interval is pressure relief, avoidance of micromechanical stimuli, and restoration of healthy foot physiology.

In our practice, we first perform a precise visual and tactile assessment of overall foot posture. Due to the antalgic gait adopted during an attack, compensatory hyperkeratoses, which are severe callus build-ups, frequently form on adjacent areas of the foot. We remove these layers extremely gently using sterile scalpel blades and rotating diamond burrs, without thermal stress to the tissue. Information on the professional use of our instruments can be found under /en/services.

In patients with existing deformities of the first ray, such as hallux valgus, the damaged joint risks accelerating the malalignment. In such cases, we manufacture custom pressure and friction protection orthoses made of medical-grade silicone. These orthoses distribute walking forces to neighbouring structures and specifically relieve pressure on the sensitive first metatarsophalangeal joint. If changes to the toenails have occurred as a result of altered gait mechanics, such as repetitive pressure against the shoe, we support healthy nail growth. As a /en/sectoral-practitioner (sektorale Heilpraktikerin), the practice owner can also conduct an extended podiatric assessment.

A further component of interval management is thermal regulation. Cryotherapy is utilized in our practice as part of tailored concepts. Targeted application in the /en/cryotherapy room can help soothe residual inflammatory processes and positively influence tissue metabolism throughout the foot, provided there are no contraindications such as severe peripheral arterial disease. All treatments are carried out in compliance with the strictest standards regarding /en/hygiene.

As a standard recommendation, we suggest treatment intervals of four to six weeks. This interval allows skin changes, pressure points, and the fit of orthotic devices to be continuously monitored and adjusted before new inflammatory stimuli arise from overload.

What you can do yourself

Preventing recurrent gout attacks relies on two pillars: targeted lifestyle modifications and consistent daily foot care. Through their daily actions, individuals have a direct influence on uric acid levels and the mechanical strain on their joints.

The following measures provide everyday support:

• Drink at least two to two and a half litres of water or unsweetened herbal tea daily to promote the renal excretion of uric acid.
• Reduce the consumption of purine-rich foods such as meat, processed meats, offal, and seafood, replacing them with low-purine protein sources such as low-fat dairy products.
• Avoid alcoholic beverages as far as possible, especially beer and spirits, as well as fructose-sweetened soft drinks.
• Wear footwear with sufficient toe room, a flexible sole, and no hard seams over the first metatarsal joint.
• Avoid crash diets or extreme fasting exercise, as the rapid breakdown of body tissue releases ketones, which inhibit renal uric acid excretion.

Daily foot care at home should focus on gentle routines. Wash the feet with lukewarm water and mild cleansing lotions. Dry between the toes carefully without rubbing vigorously. After washing, applying urea-containing lotions at a concentration of five to ten percent is recommended to maintain tissue elasticity. When trimming toenails, ensure the corners are not cut deeply to prevent injuries to the nail fold.

Common mistakes

In podiatric practice, we regularly observe recurring habits that inadvertently increase the risk of recurrent inflammation in the first metatarsophalangeal joint. A widespread mistake is applying ice packs or freezer bags directly to the skin without a protective cover during an attack. Extreme cold causes abrupt vasoconstriction of the capillary vessels and lowers tissue temperature to such an extent that uric acid crystallisation in the joint space can actually be accelerated. Cold compresses should always be wrapped in a cloth and applied at a moderately cool temperature.

Another mistake involves behaviour during symptom-free phases. As soon as pain subsides, many individuals discontinue prophylactic measures and revert to former dietary habits. Because crystal deposits in the joint do not disappear instantly, but rather dissolve very slowly over months, this carelessness frequently leads to rapid recurrences.

Mistakes also frequently occur during self-care of the feet. Using callus planes, blades, or aggressive corn plasters independently around the sensitive first metatarsophalangeal joint carries severe infection risks. Even minor cuts can act as entry portals for pathogens into the previously damaged soft tissue. Finally, continuing to wear tight or overly rigid footwear maintains continuous pressure on the joint, preventing microscopic tissue irritation from healing fully.

Current evidence and scientific context

Scientific research into gout pathophysiology and therapeutic intervention options has advanced significantly over recent decades. Evidence confirms that a sustained reduction of serum uric acid levels below the target threshold of six milligrams per decilitre (360 micromoles per litre) is necessary to achieve full dissolution of existing tissue urate crystals [1].

Guidelines from the European Alliance of Associations for Rheumatology (EULAR) and the German Society of General Practice and Family Medicine (DEGAM) emphasize the necessity of combining pharmacological urate lowering with non-pharmacological lifestyle modifications [2]. Studies clearly demonstrate that dietary changes alone usually reduce uric acid levels by only about one to two milligrams per decilitre. Nevertheless, this reduction is often the decisive factor in minimizing the frequency of acute attacks when combined with medical therapy [3].

Regarding podiatry and biomechanics, clinical studies demonstrate that targeted podiatric interventions and pressure-relieving orthoses can significantly reduce pain intensity during weight-bearing [4]. By stabilizing the first ray and reducing peak pressure values beneath the first metatarsal head, the risk of secondary joint degeneration is reduced. Furthermore, studies on cryotherapy demonstrate that controlled, large-surface cold application during the symptom-free interval can exert positive effects on inflammatory mediators in soft tissue without increasing the risk of local crystallisation, provided parameters are precisely controlled [5].

Treatment in Memmingen

At the FREITAG® Podologie GmbH practice in Memmingen, we provide professional care for patients with gout throughout symptom-free phases. Located conveniently at Kempterstr. 25, 87700 Memmingen, our practice provides specialized podiatric care for individuals from Memmingen, as well as the entire Unterallgäu, Oberschwaben, and Allgäu regions.

Under the professional direction of Helga Maria Freitag, we develop an individualized care and pressure-relief concept for your foot health. We carefully tailor our treatments, painlessly remove uncomfortable callus layers, and fit custom pressure-protection components as required. If you would like expert advice or wish to schedule an appointment, please visit our page /en/contact.

Systemic pharmacological therapy and the mechanism of mobilization attacks

Pharmacological management of gout is strictly divided into acute therapy and long-term urate-lowering interval therapy. During an acute attack, non-steroidal anti-inflammatory drugs (NSAIDs) such as naproxen or indomethacin, short-term glucocorticoid administration, and colchicine are primarily used. According to current EULAR recommendations, colchicine is administered at low doses. Dosing typically begins at one milligram, followed by 0.5 milligrams after one hour. This meadow saffron alkaloid inhibits microtubule polymerisation in neutrophilic granulocytes, directly interrupting the inflammatory cascade within the joint space.

Following resolution of acute inflammation, long-term maintenance therapy aims to permanently lower serum uric acid levels below 6.0 milligrams per decilitre, or below 5.0 milligrams per decilitre in tophaceous gout. Uricostatic agents such as allopurinol or febuxostat, which inhibit the enzyme xanthine oxidase, are available for this purpose. If these agents prove insufficient or are not tolerated, uricosuric drugs such as benzbromarone are utilized, which block uric acid reabsorption in the renal tubules.

Paradoxically, initiating treatment with uricostatic agents frequently triggers a mobilization attack. The rapid drop in plasma uric acid concentration dissolves the outer surface of existing urate crystal deposits. Consequently, sharp crystal fragments flake off into the synovial fluid, irritating the tissue once again. To prevent these recurrent reactions, allopurinol dosage is titrated gradually starting from 100 milligrams per day. Additionally, concomitant prophylaxis with low-dose colchicine at 0.5 milligrams daily is prescribed for three to six months.

Morphological sequelae and biomechanical chain reactions

If urate crystals remain undetected or inadequately treated in the first metatarsophalangeal joint over years, chronic subclinical inflammation leads to irreversible structural joint damage. Radiographs show characteristic erosive changes with overhanging bony margins, known as punched-out lesions, as well as progressive joint space narrowing. This gout-induced destruction frequently culminates in secondary osteoarthritis, known as hallux rigidus.

A physiological gait pattern requires dorsiflexion of at least 60 degrees at the first metatarsophalangeal joint during the late stance phase. If this mobility is absent due to bony appositions or fibrotic capsular contractures, the body employs biomechanical compensations. In a functional movement analysis, a 54-year-old male patient with a ten-year history of gout demonstrated a fixed extension deficit of 25 degrees at the affected first ray. This resulted in increased pressure load beneath the second and third metatarsal heads, causing painful callus formation. Furthermore, a rotational strain affected the entire kinetic chain up to the sacroiliac joint.

In the long term, altered mechanics also compromise peripheral soft tissues and tendon sheaths. In particular, the tendon of the extensor hallucis longus muscle and the sesamoid bones beneath the first metatarsal head experience increased tensile and compressive stress. The synovial membranes of these tendon sheaths react to continuous irritation with thickening inflammatory processes, chronifying pain symptoms independently of acute gout flares. Targeted manual relief techniques and biomechanical corrections can break this debilitating vicious cycle during symptom-free intervals.

Systemic comorbidities and drug interactions

Hyperuricaemia rarely occurs as an isolated metabolic problem; instead, it is closely linked with metabolic syndrome. Arterial hypertension, obesity, hyperlipidaemia, and impaired glucose tolerance mutually reinforce each other in their pathophysiology. Reduced renal perfusion in chronic hypertension decreases glomerular filtration capacity, further lowering renal uric acid excretion. Simultaneously, fatty liver disease leads to increased uric acid production in the organism through altered purine synthesis.

When adjusting pharmacological treatment for comorbidities, prescribed medications must be reviewed carefully for interactions with uric acid metabolism. Thiazide diuretics such as hydrochlorothiazide and loop diuretics such as furosemide compete directly with uric acid at the transport systems of the proximal renal tubules, thereby increasing uric acid reabsorption into the blood. Low-dose acetylsalicylic acid at 100 milligrams per day also measurably inhibits renal urate excretion. Conversely, the angiotensin II receptor blocker losartan exhibits uricosuric properties, representing a preferred treatment option in hypertensive gout patients.

Alongside the musculoskeletal system, the renal system is particularly vulnerable to structural sequelae caused by crystal precipitation. If monosodium urate crystals deposit in the renal medulla, chronic interstitial nephritis develops, which can ultimately lead to renal failure. Urate stones in the renal pelvis or ureter also cause painful colic and significantly increase the risk of ascending urinary tract infections. Regular monitoring of renal parameters and urine pH is therefore a key element in long-term patient management.